Evidence map›Paper›PMID 27495870›Full record

ArticleBiochemical and biophysical research communications2016

Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells.

Robert P Sparks, Wayne C Guida, Mark P Sowden, Jermaine L Jenkins, Matthew L Starr, Rutilio A Fratti, Charles E Sparks, Janet D Sparks

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Robert P SparksSchool of Molecular and Cellular Biology, Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
Wayne C GuidaDepartment of Chemistry, University of South Florida, Tampa, FL 33520, USA.
Mark P SowdenCardiovascular Research Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.
Jermaine L JenkinsDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.
Matthew L StarrSchool of Molecular and Cellular Biology, Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
Rutilio A FrattiSchool of Molecular and Cellular Biology, Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
Charles E SparksDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Janet D SparksDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address: Janet_Sparks@urmc.rochester.edu.
University of Rochester Medical Center · USUniversity of Illinois Urbana-Champaign · USUniversity of South Florida · US

Funding

Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
Allosteric Regulation of SNAREs and the Rab GEF Mon1 by PhosphoinositidesR01GM101132 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI FRATTI, RUTILIO A · 2012 to 2016
$1.4M
Postprandial insulin regulation of B100 and importance to VLDL1 secretionR01DK100163 · NIDDK · UNIVERSITY OF ROCHESTER · PI SPARKS, JANET DEHOFF · 2014 to 2015
$614k
NIDDK NIH HHS R01 DK100163NIGMS NIH HHS R01 GM101132NIGMS NIH HHS T32 GM070421
6 · The paper itself

Abstract

Studies examining the relationship between cellular sortilin and VLDL-B100 secretion demonstrate inconsistent results. Current studies explore the possibility that discrepancies may be related to insulin sensitivity. McArdle RH7777 cells (McA cells) cultured under serum enriched conditions lose sensitivity to insulin. Following incubation in serum-free DMEM containing 1% BSA, McA cells become insulin responsive and demonstrate reduced apo B secretion. Current studies indicate that insulin sensitive McA cells express lower cellular sortilin that corresponds with reduction in VLDL-B100 secretion without changes in mRNA of either sortilin or apo B. When sortilin expression is further reduced by siRNA knockdown (KD), there are additional decreases in VLDL-B100 secretion. A crystal structure of human sortilin (hsortilin) identifies two binding sites on the luminal domain for the N- and C-termini of neurotensin (NT). A small organic compound (cpd984) was identified that has strong theoretical binding to the N-terminal site. Both cpd984 and NT bind hsortilin by surface plasmon resonance. In incubations with insulin sensitive McA cells, cpd984 was shown to enhance VLDL-B100 secretion at each level of sortilin KD suggesting cpd984 acted through sortilin in mediating its effect. Current results support a role for sortilin to facilitate VLDL-B100 secretion which is limited to insulin sensitive McA cells. Inconsistent reports of the relationship between VLDL-B100 secretion and sortilin in previous studies may relate to differing functions of sortilin in VLDL-B100 secretion depending upon insulin sensitivity.

Indexed as

Insulin ResistanceAdaptor Proteins, Vesicular TransportAnimalsApolipoprotein B-100Binding SitesCell LineGene Knockdown TechniquesHumansInsulinLipoproteins, VLDLMolecular Docking SimulationRats, Sprague-DawleySortilinAdaptor Proteins, Vesicular TransportApolipoprotein B-100InsulinLipoproteins, VLDLSortilinApo BLiverNeurotensinSortilinSurface plasmon resonanceVLDL-B100

Identifiers

PMID27495870
PMCPMC5002383
OpenAlexW2479716850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.